Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 435 | -11,170 | 1,011 | 1,722 | -5,939 |
| Depreciation Amortization | 592 | 830 | 593 | 460 | 428 |
| Other Working Capital | -1,143 | 40 | -238 | 1,233 | -2,473 |
| Other Operating Activity | 5 | -10 | 21 | 54 | 200 |
| Operating Cash Flow | $-112 | $-10,310 | $1,387 | $3,469 | $-7,784 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 855 | N/A | N/A | N/A | N/A |
| PPE Investments | -45 | -520 | -1,159 | -520 | -283 |
| Other Investing Activity | 0 | 9,580 | -3,415 | -5,330 | -10,937 |
| Investing Cash Flow | $811 | $9,060 | $-4,574 | $-5,850 | $-11,220 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 20,031 | N/A | N/A | N/A | N/A |
| Debt Repayment | -20,093 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 54 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 1,200 | 1,203 | 3,961 | 24,626 |
| Financing Cash Flow | $-9 | $1,200 | $1,203 | $3,961 | $24,626 |
| Beginning Cash Position | 204 | 5,250 | 7,236 | 5,656 | 34 |
| End Cash Position | 894 | 5,200 | 5,253 | 7,236 | 5,656 |
| Net Cash Flow | $690 | $-40 | $-1,983 | $1,580 | $5,622 |
| Free Cash Flow | |||||
| Operating Cash Flow | -112 | -10,310 | 1,387 | 3,469 | -7,784 |
| Capital Expenditure | -45 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -156 | -10,310 | 1,387 | 3,469 | -7,784 |